NDC11 00955390003
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00955-3900-03 | 00955-3900 |
| 00955-3900-3 | 00955-3900 |
| 0955-3900-03 | 0955-3900 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Insulin glargine U-300 Max | INSULIN GLARGINE | Sanofi-Aventis U.S. LLC | 99ea856d-9562-443a-9422-1006a3cff2f4 | 2025-05-30 | Warnings, Adverse reactions | 0955-3900-03 0955-3900 00955390003 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.